Recursion Pharmaceuticals RXRX
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q1 | 5.29 | 934 | -20.57 | -202 | -14.71 | 1,305 |
| 2024Q4 | 6.76 | 1,035 | -22.95 | -179 | -16.45 | 1,449 |
| 2024Q3 | 6.59 | 525 | -17.28 | -96 | -12.76 | 726 |
| 2024Q2 | 7.50 | 584 | -19.79 | -98 | -14.63 | 776 |
| 2024Q1 | 9.97 | 401 | -21.14 | -91 | -15.08 | 558 |
| 2023Q4 | 9.86 | 463 | -20.63 | -93 | -14.48 | 654 |
| 2023Q3 | 7.65 | 438 | -20.51 | -93 | -14.34 | 631 |
| 2023Q2 | 7.47 | 469 | -17.07 | -77 | -11.86 | 667 |
| 2023Q1 | 6.67 | 430 | -14.26 | -65 | -9.83 | 627 |
| 2022Q4 | 7.71 | 486 | -13.16 | -57 | -8.76 | 701 |
| 2022Q3 | 10.64 | 388 | -14.64 | -60 | -9.41 | 612 |
| 2022Q2 | 8.14 | 438 | -14.08 | -66 | -9.32 | 673 |
| 2022Q1 | 7.16 | 494 | -10.80 | -56 | -8.33 | 734 |
| 2021Q4 | 17.13 | 543 | -11.37 | -65 | -10.23 | 610 |
| 2021Q3 | 23.01 | 599 | -7.64 | -47 | -6.99 | 659 |
| 2021Q2 | 36.50 | 643 | -43 | -8.94 | 699 | |
| 2021Q1 | -233 | -31 | -10.77 | 272 | ||
| 2020Q4 | -206 | -26 | 299 | |||
| 2020Q3 | -24 | |||||
| 2020Q2 | -19 |